• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / NEWS . . . . . . . . / Vaccine Adverse Events / Vaccine Associated Disorders / Autism / Neurotransmitters in autism and role of calcium signalling

Neurotransmitters in autism and role of calcium signalling

April 25, 2011 By Jonathan

Autism Calcium Channelopathy

Abnormalities in neurotransmitter systems have frequently been recorded in autism. Clinical observations include both elevated and lowered levels of various neurotransmitters compared to controls, including alterations in monoamine metabolism [3654486, 2653386, 3215884], neurotransmitter peptides [9018016, 9315980], with considerably raised levels of beta-endorphin (for vasopressin/oxytocin see Hormones) and altered activities of cholinergic receptors, with binding of muscarinic M(1) receptor being up to 30% and that of nicotinic receptors being 65%-73% lower in the autistic group compared to controls [11431227]. Postmortem brain examination noted abnormalities of the glutamate neurotransmitter system in autism, with specific abnormalities in the AMPA-type glutamate receptors and glutamate transporters in the cerebellum [11706102]. Expression of several types of GABA receptors is altered in brains of subjects with autism, with levels being significantly reduced in autism compared to controls [18821008, 19002745].

Dysregulations of serotonergic systems in particular have been documented, such as abnormalities in brain serotonin sythesis, with significant reductions in synthesis capacity compared to controls [10072042, 9382481], while at the same time plasma levels of serotonin and free thryptophan appear to be on average 30-50% percent higher in individuals with autism [6204248]. Autoantibodies to serotonin receptors [9067002] and reduced receptor binding have also been recorded [16648340]. Of note is that one study found correlation of elevated plasma serotonin levels and the the major histocompatibility complex (MHC) types associated with autism [8904735].

Calcium influx through VGCCs is a key step in secretion of neurotransmitters, for example serotonin [16047543]. Due to vesicle priming in neuronal excytosis, the influx of calcium ions is all that is needed to trigger nearly instantaneous neurotransmitter release in neurons [12043844]. Moreover, some findings indicate that its excessive entry through LTCC during early development may to alter neuronal response properties at later ages [9437025]. Especially in developing brain modulation of neurotransmitter release by dihydropyridine-sensitive calcium channels involves tyrosine phosphorylation. As the neurons develop a network of neurites, both tyrosine phosphorylation and LTCC activity seem to decrease [9987031, 11226706] (see Brain). This transmitter-secretion effect of LTCC is G-protein-linked and sensitive to pertussis toxin treatment [8994064]. Influx of calcium through N-type VGCC directly stimulates dopamine release and this effect can be attenuated by chalcium channels blockers [11769325, 15272204]. The involvement of LTCC-linked IP3-sensitive intercellular stores in the calcium-triggered release of dopamine and acetylcholine has also been observed [14657041]. Secretion of beta-endorphin, whose levels are significantly elevated in autism, is also triggered by calcium influx into the cell and can be lowered in vitro by applying calcium channel blockers [2428932, 10371405].

Following the findings of significant modifications of catecholamine metabolites in autism it may be worth mentioning that the activities of Catechol-O-methyl transferase (COMT), an enzyme involved in the breakdown of the catecholamine neurotransmitters, are inhibited by raised calcium levels in tissue [12170607]. Additionally, a small pilot study examining administration of tetrahydrobiopterin (R-BH4), a cofactor for tyrosine hydroxylases in the pathway of catecholamines and serotonin, reported amelioration of several autistic traits in study subjects. Decreased dopamine D2 receptor binding was also reported (see below) [9236697]. Tyrosine hydroxylase (TH) is an enzyme of central importance in catecholamine biosynthesis and the expression level of its gene is controlled by several calcium signalling pathways, most importantly LTCC-regulated CREB (see Brain) [15001085, 9645965]. In so called Tottering mice, an animal model with inherited mutation in calcium channels, the increased density of LTCC in the brain is followed by abnormal regulation of tyrosine hydroxylase. In vivo chronic nimodipine treatment was shown to significantly reduce the expression of TH mRNA in these mice [14715436].

In vivo application of calcium channel agonist and antagonists points to a possible role played by calcium inward currents in synthesis and metabolism of dopamine and serotonin in brain, with different effect observed in specific areas of rodent brain [7683338, 2431107, 7545305]

Read More…

Related

Filed Under: Autism, Nervous System, Science & Medicine, Vaccine Science Tagged With: autism, clinical studies, dopamine, neurotransmitters, serotonin

Comments

  1. marwa says

    October 11, 2016 at 8:14 am

    as a mother of an autistic child what can I do now to help my boy?? is there a special calcium formula ?

Trackbacks

  1. Convergence Pharmaceuticals Announces Phase I Trial Start of CNV2197944 for Chronic Pain | Peculiaris says:
    April 25, 2011 at 11:54 pm

    […] Neurotransmitters in autism and role of calcium signalling … […]

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Post Cervarix Syndrome: Eleanor – Kettering, Northamptonshire, UK

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

The Gardasil Hoax and Cervical Cancer

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2025 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in